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Abstract 
Vitamin C (ascorbic acid) is a naturally occurring, powerful anti-oxidant with the potential to deliver 
numerous benefits to the skin when applied topically. However, topical use of this compound is 
currently restricted by an instability in traditional formulations and the delivery and eventual fate of 5 
precursor compounds has been largely unexplored. Time of flight secondary ion mass spectrometry 
(ToF-SIMS) is an emerging technique in the field of skin research and offers detailed chemical 
analysis, with high mass and spatial resolution, as well as profiling capabilities that allow analysis as a 
function of sample depth. This work demonstrates the successful use of ToF-SIMS to obtain, in situ, 
accurate 3D permeation profiles of both ascorbic acid and a popular precursor, ascorbyl glucoside, 10 
from ex vivo porcine skin. The significant permeation enhancing effect of a supramolecular gel 
formulation, produced from an amphiphilic gemini imidazolium-based surfactant, was also 
demonstrated for both compounds. Using ToF-SIMS, it was also possible to detect and track the 
breakdown of ascorbyl glucoside into ascorbic acid, elucidating the ability of the hydrogel formulation 
to preserve this important conversion until the targeted epidermal layer has been reached. This work 15 
demonstrates the potential of ToF-SIMS to provide 3D permeation profiles collected in situ from ex 
vivo tissue samples, offering detailed analysis on compound localisation and degradation. This type of 
analysis has significant advantages in the area of skin permeation, but can also be readily translated 
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profiling. 
1. Introduction 20 
Vitamin C (ascorbic acid) is well established as a natural anti-oxidant (Bendich et al., 1986). 
Topical application of this compound has shown success in both protecting against UV-
induced oxidative stress (Darr et al., 1992; Offord et al., 2002) and offering regenerative 
properties, with a clinical improvement in the microstructure of aged skin linked to a 
stimulation of collagen synthesis (Humbert et al., 2003; Murad et al., 1983; Phillips et al., 25 
1994). These effects, coupled with the ability to combat hyperpigmentation (Farris, 2005), 
have resulted in ascorbic acid becoming a popular ingredient regularly employed in cosmetic 
products, especially anti-aging focused products. Topical ascorbic acid has also shown 
potential for clinical use, demonstrating both anti-inflammatory and wound healing properties 
(Farris, 2005). However, due to its proficiency as an antioxidant, it is readily oxidised, 30 
especially in aqueous-based systems. Formulation for topical application therefore typically 
results in rapid degradation of the compound, drastically reducing the stability and shelf life of 
the product.  
 
A popular solution to this issue, especially in the cosmetics industry, is the use of precursor 35 
compounds. These are typically ester or ether derivatives that offer improved stability and are 
proposed to be enzymatically converted to ascorbic acid within the skin (Farris, 2005; Pullar et 
al., 2017; Stamford, 2012). The clinical effects of several derivatives have been demonstrated, 
as reviewed by Farris (Farris, 2005). However, their permeation efficiencies and mechanisms 
of action are still largely unexplored, including their rate and extent of conversion into ascorbic 40 
acid (Pullar et al., 2017; Stamford, 2012). These are all parameters that cannot be easily 
observed using the techniques typically applied for skin permeation analysis.  
 
Novel delivery vehicles are an alternative option, either to stabilise ascorbic acid for topical 
delivery or to enhance the permeation of precursor compounds. Research focused on 45 
ascorbic acid delivery includes incorporating compounds into nanocarriers, such as liposomes 
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(Zhou et al., 2014), and alternative formulation types, such as anhydrous suspensions (Heber 
et al., 2006). Recent work in the field of topical delivery has demonstrated the success of a 
novel gelator, specifically an amphiphilic gemini imidazolium-based surfactant, to produce 
supramolecular hydrogels that are able to incorporate drug compounds and facilitate 50 
enhanced skin permeation (Limon et al., 2017; Limon et al., 2017, 2015; Rodrigues et al., 
2014). Supramolecular gels are well suited to topical application as they are both soft and 
non-permanent. It has been demonstrated that these novel gel formulations are simple and 
quick to produce and are extremely versatile. To date, these novel gel formulations have been 
tested on a range of compounds with diverse molecular structures, most recently three 55 
pharmaceuticals currently employed in commercial formulations, triamcinolone acetonide, 
brimonidine tartrate and betamethasone 17-valerate (Limón et al., 2017). Limón et al. 
demonstrated that “drug release was up to 10 times faster and retention of the drug within the 
skin was up to 20 times more effective” when the gel formulation was applied vs. the 
commercial product (Limón et al., 2017). These gels therefore offer a promising prospect to 60 
improve localised skin delivery, but have yet to be explored for the delivery of popular 
cosmetic actives, such as ascorbic acid.   
 
Understanding the skin permeation of exogenous compounds is an area of research that is 
essential to many industries. Whether the aim is to facilitate permeation (pharmaceutical or 65 
cosmetic products) or to prevent it (pesticides or pollutants), detailed chemical analysis is 
crucial. Information regarding the permeation depth of a compound into skin tissue is key for 
the assessment of targeted skin delivery into the epidermis or dermis. It is also useful to 
explore effects such as permeation enhancement and the location of compound degradation 
within the skin, whether unsolicited or by design.  The industrial standard for assessing skin 70 
permeation is to conduct in vitro Franz cell diffusion experiments combined with 
chromatographic mass spectrometry (MS) analysis (Franz, 1975; Friend, 1992). While this 
method works well for assessing transdermal permeation, through routine analysis of the 
underlying receptor solution, acquiring a direct permeation profile for compounds residing 
within the skin tissue itself is more challenging. Tape stripping can be used to sample the 75 
stratum corneum (Celebi et al., 2016) and horizontal cross-sectioning can obtain skin slices 
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from varying depths (Lapteva et al., 2014), but chromatographic MS analysis of these samples 
relies on both efficient compound extraction and successful column isolation from co-extracted 
native components. In addition, these processes all require an extra preparation step and 
further manipulation of the tissue. Tape stripping has been shown to be subject to large 80 
variability, dependent on numerous parameters that have to be strictly controlled (reference). 
The separation of epidermal and dermal layers requires exposure to either heat or harsh 
chemicals. Cross sectioning requires prior embedding of the tissue and again exposure to 
exogenous chemicals, which Sjövall et al. has recently suggested can have a “compromising 
effect” on the localisation of lipids within a tissue ((Sjövall et al., 2018). 85 
 
Recent advancements in mass spectrometry imaging (MSI) techniques have seen them rise in 
popularity for chemical analysis of biological samples, as reviewed in detail by Chughtai and 
Heeren (Chughtai and Heeren, 2010). These techniques offer a key advantage over 
chromatographic MS, through their ability to raster a sample surface and produce chemical ion 90 
maps, providing information on the spatial distribution of compounds across a surface. This is 
especially useful when assessing the localisation of either endogenous or exogenous 
compounds within biological material, such topical product delivery to the skin. 
 
Time of flight secondary ion mass spectrometry (ToF-SIMS) is a type of MSI technique and 95 
requires no prior sample preparation, apart from a requirement for the sample to be placed 
under high vacuum. It can analyse a multitude of samples, from tissue sections (Gamble et al., 
2015) to individual cells (Brison et al., 2011) and can conduct simultaneous analysis of all 
components within a sample. ToF-SIMS is therefore able to provide a rapid assessment of the 
chemistry within a biological sample, without the need for extensive method development to 100 
extract and separate components of interest, an aspect of chromatographic MS that can 
sometimes prove time-consuming. ToF-SIMS is unique as an MSI technique, as it has the 
ability to conduct both surface and depth profile analysis. As well as rastering across a 
surface, ToF-SIMS is able to sputter through a sample and concurrently collect MS information 
as a function of sample depth. This enables the production of 3D chemical profiles, without the 105 
need for the sample to be sectioned or deconstructred. One disadvantage of this technique is 
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that it only provides semi-quantitative information, providing a relative comparison of skin 
permeation rather than calibrated compound concentration.   
 
Numerous studies have shown successful surface analysis of skin samples, both tape stripped 110 
stratum corneum (Holmes et al., 2017; Judd et al., 2013; Starr et al., 2016) and cross-
sectioned ex vivo tissue (Kezutyte et al., 2013; Kubo et al., 2013; Monteiro-Riviere et al., 
2011; Sjövall et al., 2014). The most recent publication regarding ToF-SIMS analysis of skin 
permeation, published in 2018 by Sjövall et al., highlights the significant advantage that can be 
provided by this technique (Sjövall et al., 2018). Using surface analysis of cross sectioned skin 115 
tissue to assess carvacrol permeation, Sjövall et al. were able to demonstrate a strong 
localisation of the compound within the dermal layer, which was in good agreement with gas 
chromatography MS data. However, the imaging capabilities of ToF-SIMS could also 
determine that the localisation within this layer did not exhibit a lateral uniformity, suggesting 
possible delivery via a follicular route. 120 
 
Similar results have been achieved using surface analysis of cross sectioned skin tissue 
(Kezutyte et al., 2013; Kubo et al., 2013; Monteiro-Riviere et al., 2011; Sjövall et al., 2014) yet 
the profiling capabilities of this technique have been explored to a much lesser extent. Sjövall 
et al. state that one drawback to their study is that the “preparation of the cross-section 125 
samples is critical and can be problematic” (Sjövall et al., 2018). In situ depth profile analysis 
of skin tissue would circumvent the need for sectioning. Yet only one study to date has 
exploited these depth profiling capabilities to assess skin permeation, successfully 
demonstrating localisation of the common hapten, nickel, in order to further investigate its role 
in contact allergy (Per et al., 2017). 130 
 
As previously discussed in detail by Judd et al. (Judd et al., 2013), other imaging techniques 
have been applied to analyse skin as a function of depth, most notably confocal laser 
scanning microscopy (Alvarez-Román et al., 2004a, 2004b; Gerger et al., 2006; Rajadhyaksha 
et al., 1995) and both stimulated Raman scattering microscopy and confocal Raman 135 
spectroscopy (Ashtikar et al., 2013; Freudiger et al., 2008; Pyatski et al., 2016; Saar et al., 
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2011). These all offer the ability to conduct 3D in vivo imaging of the skin. However, ultimately, 
they do not possess the chemical sensitivity and specificity offered by MS techniques. This 
makes it hard to distinguish between native skin components and certain exogenous 
compounds, especially cosmetic actives which are often based on naturally occurring 140 
compounds. Furthermore, assessment of compound metabolism is also difficult without the 
specificity provided by detailed MS analysis. 
The aim of this work was to explore ToF-SIMS 3D profiling as a method to provide in situ skin 
permeation analysis of active compounds within ex vivo skin tissue. Specifically, to investigate 
the permeation enhancing effects offered by a supramolecular hydrogel formulation for the 145 
localised delivery of both ascorbic acid and a popular precursor, ascorbyl glucoside. 
2. Experimental 
2.1 Materials 
Ethanol (ACS reagent grade) and phosphate buffered saline tablets were purchased from 
Fischer Scientific, UK. 1,3-bis[(3-octadecyl-1-imidazolio)methyl]benzene dibromide was 150 
synthesised at the University of Barcelona (Spain) according to the previously reported 
protocol (Rodrigues et al., 2014). Ascorbic acid and ascorbyl glucoside were purchased from 
DSM, Switzerland and DKSH, UK respectively. 10 % neutral buffered formalin, xylene 
(histological grade) and paraffin wax were purchased from Sigma Aldrich, UK.  
 155 
2.2 Skin Sample Preparation 
Porcine ears were obtained from animals aged 4-6 months, reared specifically for food. This 
ensured that removing the skin tissue was a secondary use of the animal. The ears were 
removed from the pig immediately after slaughter, prior to cleaning or hair removal. The skin 
was stored for a maximum of 24 hours at 4 °C, after which the tissue was washed with 160 
ultrapure water only and the hair trimmed with scissors. Using a scalpel, the outer-ear skin 
was detached from the underlying cartilage and any excess subcutaneous fat was removed. 
The skin was wrapped in aluminium foil and stored at -20 °C for a maximum of 3 months prior 
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to use. Full thickness skin sections (approximately 2mm) were used for both the cross 
sectioning and for the Franz cell permeation experiments. 165 
 
The effect of freezing and thawing on the barrier function of ex vivo skin tissue has been 
largely debated. However, recent studies on ex vivo human tissue stored at both -20 °C 
(Jacques-Jamin et al., 2017) and -85 °C (Barbero and Frasch, 2016) conditions observed no 
significant change in the permeation of several model compounds. The effect of freezing on 170 
skin metabolism is another issue that arises from the use of ex vivo skin tissue. It is largely 
assumed that previously frozen skin tissue is rendered metabolically inactive. However, 
several studies have shown that there is still some metabolic activity present in ex vivo skin 
that has been frozen and thawed (Hewitt et al., 2000; Nicoli and Santi, 2007). It is important to 
note that all skin samples used in this study have been stored and prepared in an identical 175 
manner. It can therefore be assumed that any permeation differences observed between 
samples are genuine and not artefacts related to sample preparation.    
 
2.3 Preparation of blank tissue cross sections  
A 1 cm × 1 cm square of porcine skin was fixed in a 10 % (v/v) formalin solution for 20 180 
minutes. After washing in phosphate buffered saline (PBS), the skin sample was then 
dehydrated using a series of ethanol solutions.  The sample was soaked in each solution for 
30 minutes, increasing in ethanol concentration from 25 - 100 % (v/v). The sample was then 
twice submerged in xylene (2 × 1 hour) and lastly twice in paraffin wax (2 × 1 hour). The 
dehydration and embedding process was conducted automatically using a tissue processor 185 
(Leica TP1020, Milton Keynes, UK). The embedded sample was then cut vertically into 
sections of approximately 10 µm using a microtome (Leica RM 2165 microtome, Leica 
Microsystems Ltd.) and mounted onto glass slides. Prior to ToF-SIMS surface analysis, the 
cross sections were paraffin-stripped in xylene and left to air dry.  
 190 
2.4 Formulation Preparation 
Both ascorbic acid and ascorbyl glucoside were prepared as phosphate buffered saline (PBS) 
solutions and supramolecular hydrogel formulations, both at 5% (w/v), see Table S1. The 
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gelator used was 1,3-bis[(3-octadecyl-1-imidazolio)methyl]benzene dibromide. To prepare the 
gel formulation, 5 mg of gelator was dissolved in 400 µL of ethanol. In a separate vial 50 mg of 195 
ascorbic acid/ascorbyl glucoside was dissolved in 600 µL of deionised water. The compound 
solution was then added to the gelator solution and stirred manually for 60 s. The mixture was 
then left undisturbed until gelation had occurred, which was confirmed using the inverted vial 
method (Rodrigues et al., 2014). Supramolecular hydrogels produced using this gelator have 
shown to be “non-irritant” when applied in vivo (Limón et al., 2015).  200 
 
2.5 Franz Cell Set-Up 
Once defrosted, circular skin samples were  cut and mounted, dermal side down, between a 
donor and receptor chamber in a Franz-type static diffusion cell set-up (Franz, 1975), with an 
exposed surface area of 0.64 cm2 and a receptor compartment volume of 9.8 mL. Three Franz 205 
cells were run per sample type. The integrity of each skin sample was assessed by electrical 
resistance using the method and guidelines described by Davies et al. (Davies et al., 2004) 
and only skin that produced an electrical resistance reading of > 10 kΩ was used. PBS 
solution (pH 7.4) was used as the receptor medium. An excess (infinite dose) of the active 
compound was applied via the donor compartment, as either a PBS solution (1 mL) or a gel 210 
formulation (200 mg). Sink conditions were maintained throughout the experiments. The skin 
was exposed to the formulation for 24 h in a water bath set to 37 °C. In-house stability studies, 
conducted previously, have demonstrated only a minimal reduction in ascorbic acid 
concentration (< 10 %) when prepared as an aqueous solution and left at 40 °C over a 24-
hour time period. Therefore, it was felt that these Franz cell conditions were appropriate for 215 
this type of permeation assessment.   
 
2.6 Post-Franz cell tissue preparation 
Previous studies (Malm et al., 2009; Van Nuffel et al., 2016) have suggested that the optimum 
preparation method for ToF-SIMS analysis of cellular material is cryofixation followed by 220 
freeze-drying. However, for tissue samples, such as full thickness skin, it can be problematic 
to ensure that the freezing process is rapid enough to prevent the formation of ice crystals. It 
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has been suggested that without cryofixation, the high vacuum environment can compromise 
the integrity of the cellular structure (Malm et al., 2009). However, it is anticipated that this 
would not significantly affect the localisation of, nor cause migration of, exogenous 225 
compounds within the skin. Following the Franz cell experiments described in Section 2.5, the 
excess formulation was removed from the skin with a spatula and the surface swabbed with a 
sponge that had been wet with distilled water, followed by a dry sponge. The skin samples 
were then dried flat under vacuum for 12 h before loading into the ToF-SIMS instrument for 
depth profile analysis. It is anticipated that as the skin is not being fixed, either chemically or 230 
through freezing, there may be some continued diffusion of the compounds through the skin 
tissue during this drying period. However, importantly, an identical preparation method is 
employed for all samples. Hence, any observed variation in permeation depth can be 
attributed to real differences between sample types.  
 235 
2.7 ToF-SIMS analysis 
Analysis was conducted using a ToF-SIMS IV instrument (IONTOF, GmbH) equipped with a 
single-stage reflectron analyser. Charge compensation of the sample was achieved using a 
low energy (< 20 eV) electron flood gun. For surface analysis, a Bi3+ beam energy of 25 keV, 
pulsed target current of ~ 0.3 pA and post-acceleration energy of 10 keV was employed. High 240 
current bunched (HC-BU) mode was used throughout and the primary ion dose density was 
maintained ≤ 1 × 1012 ions/cm2 to ensure static conditions. The Bi3+ beam was directed at the 
sample at an angle of 45 °C with a focused size of 1-2 ≤ µm. Dual beam dynamic SIMS was 
conducted using an Ar gas cluster ion beam (GCIB) and Bi3+ liquid metal ion gun (LMIG) for 
sputtering and analysis respectively. The LMIG settings were as described previously. The 245 
GCIB used was a 20 keV Ar1900 beam with a target current of 10 nA. Non-interlaced depth 
profiling was employed, whereby the sputter and analysis ion beams do not operate 
simultaneously but at regular alternating intervals, with a single cycle consisting of 10 seconds 
sputtering, a 0.5 second pause and 3.25 seconds of analysis. A region of 500 µm × 500 µm 
was sputtered and a 200 µm × 200 µm region within the centre of the sputtered crater was 250 
analysed. Data was acquired and analysed using SurfaceLab 6 software (IONTOF, GmbH) 
and all exported peak intensities were dead time corrected and normalised to the total ion 
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count of their associated spectrum. Two areas were analysed per individual skin section, 
producing n=6 datasets for each sample type.  
3. Results and Discussion 255 
3.1 Validation of native tissue analysis using dynamic ToF-SIMS  
Prior to permeation analysis, substantial method development was conducted to establish a 
reliable ToF-SIMS depth profiling method for native skin tissue. The final parameters provide a 
method that can profile through skin tissue at a practical rate and produce accurate chemical 
information. Optical profilometry was initially used to visualise the resulting sputter crater (Fig. 260 
S1) and stable ion intensities (Fig. 1a (i)) and consistent spatial distributions (Fig. 1b (i)) were 
observed as a function of depth for generic tissue markers, such as CN -. Typical depth profile 
analysis relies on the calculation of a sputter rate, to provide a 3D chemical profile that is 
calibrated to sample depth. Preliminary analysis was conducted using optical profilometry to 
measure the depth of sputtered craters within the skin tissue. However, this method failed to 265 
produce repeatable results, confirming the difficulties previously shown to be associated with 
calculating a sputter rate for multi-layered samples (Bailey et al., 2015; Seah et al., 2015; 
Taylor et al., 2015). The average sputter rate calculated from these experiments was 0.15 
µm/s (data not shown) and this has been used to add an estimated skin depth scale to the 
ToF-SIMS profile graphs (Figures 1, 3 & 4) for reference purposes.  270 
 
To circumvent the issues arising from sputter rate calculations, it was decided to instead look 
for inherent layer markers to identify the relative position within the skin when profiling. 
Although the stratum corneum contains different quantities of lipid species compared to the 
remaining epidermal layer, the nature of these lipids is not significantly different (Lampe et al., 275 
1983). Therefore, there were few ions that demonstrated obvious changes in intensity as a 
function of sample depth. However, one clearly observed difference was the absence of 
phospholipids within the stratum corneum. These lipids are present at high levels in the 
underlying epidermis but decrease towards the skin surface due to the keratinisation process 
(Lampe et al., 1983). ToF-SIMS spectra for this lipid class are typically dominated by 280 
numerous phosphate-containing fragments, in particular, high intensity PO3-/PO2- ions 
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(Schaepe et al., 2017; Sjövall et al., 2014). These ions are absent from the initial portion of 
profiled skin tissue, which is clearly demonstrated when the data is presented as either a 
depth profile graph (Fig. 1a (ii)) or as a 3D ion map (Fig. 1b (ii)). The absence of these ions 
therefore indicates the location of the stratum corneum. As highlighted in Figure 1a (ii), at a 285 
specific depth into the profile (~ 170 sputter seconds) there is a significant increase in PO3- 
intensity, corresponding to the interface between the stratum corneum and underlying 
epidermis being reached. The use of ToF-SIMS to demonstrate this localisation of PO3- ions 
within skin has recently been shown by Sjövall et al. (Sjövall et al., 2014), through surface 
analysis of cross-sectioned porcine tissue. Using a similar sample set-up, we were able to 290 
corroborate this, highlighted in Figures 1c (i) and (ii), and the use of the dynamic SIMS 
approach allowed novel observation of this PO3- absence in situ. When attempting to monitor 
the permeation of an active compound, this sample-specific location of the stratum corneum 
interface can therefore be used to assess whether the compound has successfully passed into 
the underlying epidermis, which is often the primary target for localised compound delivery.  295 
 
For any given skin sample, the intrinsic stratum corneum thickness will vary, highlighted in 
Figure 1c (ii). Therefore, for depth profile analysis, the epidermal interface will be reached at 
different depths within any given analysis region, which explains the gradual PO3- intensity 
increase observed in Figure 1a (ii). However, for the purpose of defining the interface depth, 300 
the sputter time relating to the onset of this intensity increase, highlighted in Fig. 1a (ii), is 
taken. It should be noted that for the experiments conducted within this study, the PO3- 
intensity profile was obtained from a blank skin sample taken from an adjacent part of the 
same porcine ear tissue. This ensured the intensity profile was not affected by phosphate ions 
originating from the formulation.  305 
 
3.2 Permeation enhancing effects of a supramolecular hydrogel formulation  
The two compounds chosen for permeation analysis, ascorbic acid and ascorbyl glucoside, 
both produce a high intensity, negative molecular ion that is distinct from any fragment ions 
found in native skin tissue, specifically C6H7O6− (m/z=175) for ascorbic acid and C12H17O11 − 310 
(m/z=337) for ascorbyl glucoside (Fig. 2). It is worth noting that the reference spectrum for 
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ascorbyl glucoside (Fig. 2b) also contains a peak at m/z=175, produced by the instrument-
induced fragmentation of this molecule into ascorbic acid. These compounds were applied to 
the skin tissue as both a PBS solution and a supramolecular hydrogel formulation. A 
comparison of the gelator reference spectrum with the reference spectra of both ascorbic acid 315 
and ascorbyl glucoside is shown in Fig. S2. This confirms that there are no peaks originating 
from the gelator material that overlap with the molecular ion peaks of the two compounds.  
 
Figure 3 contains example data showing successful depth profile analysis of skin tissue 
applied with the four different formulations, displaying the intensity of the respective molecular 320 
ion as a function of skin depth. The full data set is displayed in Figure S3. The data is 
presented as both depth profile graphs and 3D secondary ion maps, with the latter elucidating 
the lateral and axial distribution of these compounds within the skin tissue. For both 
compounds, ascorbic acid (Fig. 3a) and ascorbyl glucoside (Fig. 3b), the data obtained 
confirms that permeation is greatly enhanced through application of the gel formulation 325 
compared to the PBS solution. The hydrogel formulation significantly increases the overall 
intensity of the molecular ions for both compounds, indicating an overall increased 
concentration permeating into the skin. In addition, both gel-applied compounds appear to 
maintain an intensity above the control level much deeper into the skin compared to the PBS 
solutions.  330 
 
Both gel-applied compounds show a significant initial increase in intensity, rather than the 
general decrease associated with the PBS solutions. These peaks in intensity are likely to be 
associated with localised “pools” of each active compound. For the ascorbyl glucoside gel 
(Fig. 3b), the decrease in intensity is prolonged until the stratum corneum interface has been 335 
reached. Yet for the ascorbic acid gel (Fig. 3a), the maximum ion intensity is reached at a 
point substantially past this interface, demonstrating the ability of the gel to increase the 
amount of ascorbic acid available in the underlying epidermal layer. This compound 
localisation can also be observed in the example 3D ion map associated with the ascorbic acid 
gel formulation, as a visible band of increased intensity (Fig. 3a).  340 
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Although permeation enhancement of ascorbic acid has been previously attempted (Lee et al., 
2017, 2003; Naveed et al., 2011) it is difficult to compare the success of this hydrogel 
formulation with other studies, as they typically use chromatography-based techniques to 
assess permeation. These studies will therefore often report a concentration or flux value for 345 
transdermal permeation, which is hard to relate to the ToF-SIMS intensity profiles. However, in 
the most recent study published on ascorbic acid enhancement, the concentration (µg/ cm2 ) 
of ascorbic acid retained in the epidermis after 24h was assessed, following the application of 
different liposome-based formulations (Maione-Silva et al., 2019). This study, by Maione-Silva 
et al., demonstrated that application via these liposome formulations resulted in between ∼1.3 350 
and 2 times more ascorbic acid present in the epidermal layer compared to the control. The 
ToF-SIMS profiles for ascorbic acid permeation obtained in this study (Fig. 3a), demonstrate 
that in the epidermal region (between ∼20 and 80 µm), the level of ascorbic acid present 
following the hydrogel application is at least 2 times more than for the PBS application. 
Although this is a rough estimate and cannot be directly calculated, it does suggest that these 355 
hydrogels are within the same level of effectiveness for enhancing epidermal delivery of 
ascorbic acid. 
 
The 3D ion maps displayed in Figure 3 indicate that in general a relatively consistent 
permeation depth was reached across the 200 µm × 200 µm analysis area. However, the 360 
permeation depth of ascorbic acid (Fig. 3a) appears to vary noticeably across this region 
following the application of the gel formulation. This may be the result of several possible 
factors, including a varied skin structure, non-uniformity in gel application onto the skin or even 
a non-uniformity in the distribution of the compound within the gel formulation itself. This 
demonstrates the variation in distribution that can occur following topical application of a 365 
compound and highlights the importance of being able to monitor this in order to understand 
the impact it has on the efficiency of the overall delivery system.  
 
Apparent for both types of formulation, a significant variation in overall ion intensity is 
observed between the two compounds, ascorbic acid (Fig. 3a) and ascorbyl glucoside (Fig. 370 
3b). However, this cannot solely be attributed to permeation of a higher concentration of 
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ascorbic acid. It is well established that ion intensities in ToF-SIMS can be affected by the 
ionisation ability of individual molecules and also by the sample environment, a phenomenon 
known as the matrix effect (Sodhi, 2004). In particular for organic samples, it has been 
demonstrated that the co-localisation of other species present in the sample can have a 375 
profound effect on ionisation and can result in both ion enhancement and suppression effects 
(Jones et al., 2007). Therefore, the effect of this on these samples needs to be further 
investigated. However, irrespective of overall ion intensity, there is a significant difference in 
permeation depth between the two compounds. This is apparent for both types of formulation 
and demonstrates that ascorbyl glucoside does not permeate as readily into the skin as 380 
ascorbic acid, most likely due to its increased molecular weight and hydrophilicity. It is, 
however, difficult to corroborate this data with previous results, as the permeation of vitamin c 
derivatives is a poorly researched area, highlighted in recent reviews by both Stamford and 
Pullar (references). There is only one study to date focused on the permeation of ascorbyl 
glucoside and currently no studies have made a comparative assessment of the permeation of 385 
ascorbyl glucoside and ascorbic acid. 
 
3.3 Insights into the enzymatic breakdown of ascorbyl glucoside  
Ascorbyl glucoside is employed in cosmetic products as an aqueous-stable derivative that is 
enzymatically converted into ascorbic acid within the skin. It was therefore proposed that the 390 
ToF-SIMS in situ analysis may be able to detect this enzymatic breakdown. Initial examination 
of the data showed that following application of ascorbyl glucoside as both the PBS solution 
and the gel formulation the molecular ion for ascorbic acid could also be detected within the 
skin tissue, as demonstrated by the example data shown in Figure 4. The full data set is 
displayed in Figure S4. However, as previously shown (Fig. 2b), the molecular ion peak for 395 
ascorbic acid (m/z = 175) is also present in the ToF-SIMS reference spectrum for ascorbyl 
glucoside, due to instrument-induced fragmentation. Therefore, for the samples applied with 
ascorbyl glucoside, it was first important to distinguish between the intensity of ascorbic acid 
related to instrument-induced fragmentation vs. the intensity produced through enzymatic 
conversion. To investigate this, the intensity ratio between the peaks at m/z = 337 (ascorbyl 400 
glucoside) and m/z = 175 (ascorbic acid) was calculated for a reference sample, consisting of 
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a homogenised mixture of skin tissue and ascorbyl glucoside, and then compared to the ratio 
observed throughout the depth profiles. On examination of the depth profile data, it was 
observed that this ratio varied from the reference, with a higher presence of ascorbic acid 
associated with increasing skin depth. This can therefore be attributed to the enzymatic 405 
conversion of ascorbyl glucoside, confirming that this transformation can be detected using the 
ToF-SIMS in situ analysis method.   
 
It was also observed that this degradation of ascorbyl glucoside varied significantly depending 
on whether it had been applied to the skin in a PBS solution or as the gel formulation. In 410 
general, for the PBS treated samples (Fig. 4, blue data), the levels of ascorbic acid relative to 
ascorbyl glucoside rapidly increase with skin depth and both ions shown an early decrease in 
intensity, reaching a control level close to the stratum corneum interface. This demonstrates 
that, when delivered as a PBS solution, the permeation of ascorbyl glucoside is restricted to 
the stratum corneum and is undergoing rapid enzymatic breakdown into ascorbic acid before 415 
the underlying epidermis has been reached. In contrast, the gel formulation appears to show 
the opposite trend (Fig. 4, red data). The initial ratio between the two peak intensities is similar 
to the one observed for the reference sample and this is maintained until the stratum corneum 
has been passed. The intensities of the ascorbyl glucoside and ascorbic acid ions then start to 
simultaneously decrease and increase respectively. This suggests that not only is the gel 420 
formulation delivering more ascorbyl glucoside into the skin (Fig. 3), but that it is also 
preserving the degradation of this compound until after the stratum corneum has been passed. 
This results in a maximum ascorbic acid intensity in the underlying epidermal layer, the 
intended target for clinical efficacy. The 3D ion maps for both the ascorbyl glucoside ion 
(m/z=337), and ascorbic acid ion (m/z=175) also highlight this phenomenon (Fig. 4b). The 425 
ascorbyl glucoside ion displays a high intensity at the surface of the skin. Whereas, the 
intensity of the ascorbic acid ion is clearly reduced at the surface of the skin and the maximum 
intensity is located deeper within the skin tissue. Although this data is purely preliminary and 
the method could be further optimised, it highlights the huge potential of ToF-SIMS to assess 
the in situ conversion of vitamin c derivatives, something which has not yet been achieved.  430 
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4. Conclusions 
This work has shown the successful incorporation of both ascorbic acid and ascorbyl 
glucoside into a supramolecular hydrogel formulation using an amphiphilic gemini 
imidazolium-based surfactant. It was demonstrated that this hydrogel formulation was able to 
significantly enhance the localised skin delivery of both compounds, resulting in an increased 435 
concentration residing in the epidermal layer of the skin, the intended delivery target for a 
cosmetic active ingredient. Significantly, it was shown that the hydrogel formulation was also 
able to preserve the enzymatic conversion of ascorbyl glucoside to ascorbic acid until after the 
stratum corneum barrier had been passed. This confirms the huge potential of these hydrogel 
formulations as topical delivery vehicles.  440 
 
The observation of this enhanced localised skin permeation was achieved using an emerging 
technique in the field of skin permeation analysis, ToF-SIMS. Using this technique, we were 
able to successfully produce accurate 3D chemical profiles to monitor the permeation of these 
compounds through ex-vivo porcine skin. This enabled compound permeation and localisation 445 
to be studied in situ across the individual skin layers. This in situ analysis offers an alternative 
approach to explore compound localisation in the skin, without the need to overcome the 
previously discussed issues regarding layer isolation. These include method variability, 
extraction of specific compounds and tissue exposure to heat and exogenous chemicals. This 
work has also highlighted the advantage of monitoring the spatial distribution of compounds 450 
within skin tissue and the unique ability of ToF-SIMS to assess this both laterally and as a 
function of depth.  
 
Although this method has been used here to monitor compound permeation through the skin, 
it has the potential to provide key information in a multitude of other biological applications. 455 
We have demonstrated the ability of this technique to chemically distinguish between subtly 
different tissue layers and also monitor compound degradation occurring within the tissue. 
This is applicable to both the intended degradation of derivatives/pro-drugs and the production 
of unwanted metabolites. It is therefore foreseeable that this method could be used to provide 
detailed analysis of exogenous compounds within other complex tissue matrixes, for example 460 
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analysis of ocular drug delivery or compound absorption within the gastrointestinal tract 
organs. 
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